"Business as usual" for HIV screening after discovery of new strain
This article was originally published in Clinica
Standard HIV screening will diagnose patients infected with a newly-discovered strain of the virus, but not differentiate this new strain from others, Clinica has learnt. The discovery of this fourth "P" variant of type-1 HIV – the others are known as M, which account for the vast majority of cases, O and N – in a Cameroonian woman hospitalised in Paris, was announced this week by French researchers. A spokesperson for the UK HIV and STI charity, the Terence Higgins Trust, told Clinica that current testing will diagnose infection without specifying the identity of the new strain.
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.